{"nct_id":"NCT02837991","title":"A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma","status":"TERMINATED","status_verified_date":"2018-11","start_date":"2016-06","start_date_type":null,"primary_completion_date":"2018-11-16","primary_completion_date_type":"ACTUAL","completion_date":"2018-11-16","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CLDX"]}